Clinical Trial Update: Neuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating neuroprotection by tocotrienols in individuals with Type 1 and Type 2 diabetes mellitus; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Diabetic Neuropathy
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Tocotrienols (tocotrienols)

Snippet

Sponsor: Universiti Sains Malaysia | Conditions: Diabetic Neuropathy, Cognitive Impairment | Phase 3 | Status: COMPLETED